DNA repair defects in prostate cancer: which consequences/treatment modalities for daily practice?


E-session 491

Expert
Carmel Pezaro'
Sheffield Teaching Hospital
Sheffield, United Kingdom
Discussant
Aurelius Omlin'
Onkozentrum Zurich
Zurich, Switzerland

This e-Session is part of the following pathway(s):
18
Jul 2019